Multiple Assemblies exist for SMTL entry 6c7i
Crystal structure of human phosphodiesterase 2A with 1-(2-chloro-5-methoxy-phenyl)-N-isobutyl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide; X-RAY DIFFRACTION 1.71 Å

	SMTL ID 6c7i.1 Ligands 1-(2-chloro-5-methoxyphenyl)-4-methyl-N-(2-methylpropyl)[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide; ZINC ION; MAGNESIUM ION Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer
	SMTL ID 6c7i.2 Ligands 1-(2-chloro-5-methoxyphenyl)-4-methyl-N-(2-methylpropyl)[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide; ZINC ION; MAGNESIUM ION Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer
	SMTL ID 6c7i.3 Ligands 1-(2-chloro-5-methoxyphenyl)-4-methyl-N-(2-methylpropyl)[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide; ZINC ION; MAGNESIUM ION Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer
	SMTL ID 6c7i.4 Ligands 1-(2-chloro-5-methoxyphenyl)-4-methyl-N-(2-methylpropyl)[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide; ZINC ION; MAGNESIUM ION Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer